Exclusive Journals Coverage articles provide quick insight and additional author perspectives on select studies recently published in Journal of Clinical Oncology and Journal of Oncology Practice.
Aug 04, 2014
Statins, the widely used drugs taken to lower cholesterol, might have another benefit—increasing survival among patients diagnosed with colorectal cancer. That’s according to a Journal of Clinical Oncology (JCO) study, published online, ahead of print, August 4.
Jul 28, 2014
“This study shows that—as opposed to an FDA black-box warning of tumor progression, shortened survival, and thrombotic risks—reimbursement has far greater impact in terms of changing physician behavior,” said study first author, Dawn L. Hershman, MD, MS . . .
Jul 16, 2014
Perspective from L. Michael Glodé, MD, FACP, FASCO, an IDEA Mentor
Jul 14, 2014
To explain the rise in oropharyngeal squamous cell carcinoma (OPSCC), researchers turned to another historic trend—the increase, since the late 1970s, in the number of people carrying human papillomavirus (HPV), an infection known to cause OPSCC . . .
Jul 07, 2014
“We wanted to determine if the association is also seen in two relatively common conditions in elderly American men—depression and prostate cancer—in terms of the effects on treatment choices as well as survival,” said Jim Hu, MD, MPH, a co-author on the study . . .
Jun 30, 2014
The study showed it was possible to successfully link a statewide registry that collects data on surgical quality with the tumor registries of 10 hospitals. The database created from the linkage will serve as a platform for a quality assessment program for rectal cancer surgery.
Jun 23, 2014
The study found that among patients with non-metastatic colorectal cancer, those who consumed more calcium and milk after their diagnosis had a lower rate of death from all causes. These same benefits were not seen in those who consumed more vitamin D . . .
Jun 16, 2014
By Jo Cavallo
Jun 02, 2014
“For one patient, a 2 or 3% absolute benefit in terms of recurrence rate may be important enough that she would choose to take chemotherapy with all of its various side effects. And for another patient, that same exact amount of benefit is not enough to warrant taking chemotherapy."